About Klarris Pharmaceuticals Private Limited
Data last updated:
Klarris Pharmaceuticals Private Limited is a private limited company based in Satara, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2020PTC338482. Its GSTIN is 27AAICK0441N1ZC (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Praveen Kumar and Bulbul Singh.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 547 Village Wadhe C Wing Flat 401 Saiabhay Co – Op, Satara, Maharashtra, India – 415011.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.73 Cr, a growth of 45% compared to the previous year. For the same year it recorded a net profit of ₹1.49 Lakh (net margin 0.5%) and EBITDA of ₹2.01 Lakh (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 229% over three years.
The company has about 9 employees on its provident fund (EPFO) records.
For more details, the company can be reached via its website klarrispharma.com.
Company details
Contact details
Klarris Pharmaceuticals Private Limited's registered office is in Satara, Maharashtra. Its website is klarrispharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address547 Village Wadhe C Wing Flat 401 Saiabhay Co – Op, Satara, Maharashtra, India – 415011
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Klarris Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Klarris Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Klarris Pharmaceuticals Private Limited, buy the company report.
Financials of Klarris Pharmaceuticals Private Limited
FY 2025 filings availableKlarris Pharmaceuticals Private Limited reported revenue of ₹2.73 Cr (up 45% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 229% over three years, including 45% growth in the latest year. EBITDA fell 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.49 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Klarris Pharmaceuticals Private Limited, buy the company report.
Board of directors of Klarris Pharmaceuticals Private Limited
Klarris Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Praveen Kumar Also directs: Sanvi Seeds & Bio Product Private Limited | Director | 02 Mar 2020 | 6 Years 8 Months | Current |
| Bulbul Singh Also directs: Sanvi Seeds & Bio Product Private Limited | Director | 02 Mar 2020 | 6 Years 8 Months | Current |
Auditor
Klarris Pharmaceuticals Private Limited is audited by JAIN KOCHAR & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAIN KOCHAR & CO. | FY 2023 | 532343 |
Shareholding
The shareholding of Klarris Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Klarris Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Klarris Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Klarris Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Klarris Pharmaceuticals Private Limited has a workforce of 9 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Klarris Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICK0441N1ZC | Maharashtra | Active | 13 May 2020 |
| 22AAICK0441N1ZM | Chattisgarh | Active | 14 Aug 2020 |
To see the full GST registrations and return filing status of Klarris Pharmaceuticals Private Limited, buy the company report.
Recent activity
Klarris Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Bulbul Singh was appointed as Director on 02 Mar 2020.
Frequently asked questions
Klarris Pharmaceuticals is an active private limited company based in Satara, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 March 2020 (6+ years old) and is registered under CIN U24230MH2020PTC338482.
Klarris Pharmaceuticals has 2 current directors:
- Praveen Kumar - Director
- Bulbul Singh - Director
The latest financial statements of Klarris Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Klarris Pharmaceuticals is 27AAICK0441N1ZC, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 22AAICK0441N1ZM (Chattisgarh).
The CIN (Corporate Identification Number) of Klarris Pharmaceuticals is U24230MH2020PTC338482. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Klarris Pharmaceuticals was incorporated on 02 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Bulbul Singh was appointed as Director on 02 Mar 2020. Praveen Kumar was appointed as Director on 02 Mar 2020.
Klarris Pharmaceuticals can be reached through the website klarrispharma.com. Its registered office is in Satara, Maharashtra, India.
The registered office of Klarris Pharmaceuticals is at 547 Village Wadhe C Wing Flat 401 Saiabhay Co – Op, Satara, Maharashtra, India – 415011.
Klarris Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
